InvestorsHub Logo
Followers 6
Posts 1087
Boards Moderated 0
Alias Born 07/18/2006

Re: Ganz post# 11709

Saturday, 01/16/2021 9:56:35 AM

Saturday, January 16, 2021 9:56:35 AM

Post# of 17422
The Adam F article re Aurinia, timed for AUPH's biggest OpEx was likely not a coincidence, as Lunacy noted on another board.

Finally saw excerpts from the article this a.m. and can see how it could be taken as pretty negative.

AF raised doubts about the IP2037 patent validity, the ability of Aurinia to market VCS against the size and prowess of GSK, without ever mentioning that Benlysta is a crappy, virtually worthless drug compared to Voclosporin.

Also, AF cast doubt on the Otsuka deal, questioned VCS side effects, cast CNI's in a negative light, and intimated that VCS was similar, etc.

Pretty sloppy and misleading article to those following Aurinia's story.

That semi-hit piece had to be responsible for yesterday's carnage, imo.

At least he stated FDA approval was expected.

Shortly after the article appeared AF posted to twitter that he was gone for a week or so. So is he off on vacation to the Swiss Alps or Caymans with bags of cash to deposit?







Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News